SIZE
RESEARCH
MARKET
DEMAND
BEAM
FORECAST
RESEARCH
AND
SIZE AND
& RESEARCH RESEARCH MARKET
SIZE
RESEARCH
MARKET
DEMAND
FORECAST
RESEARCH
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence Increased Uptake of Hormone Therapies and Approval of Novel Biologics
AND
SIZE AND
& RESEARCH RESEARCH
FORECAST
TELEPHONE: +1 (800) 910-6452 E-MAIL: sales@researchbeam.com
SIZE
RESEARCH
MARKET
DEMAND
BEAM
FORECAST
RESEARCH
AND
SIZE AND
& RESEARCH RESEARCH MARKET
SIZE
RESEARCH
MARKET
DEMAND
FORECAST
RESEARCH
AND
SIZE
No of Pages : 250
AND
& RESEARCH RESEARCH
FORECAST
Report Overview Urological cancers are thought to account for 19.5% of global cancer prevalence, with kidney, prostate, testicular and bladder cancer - the key indications covered in this report - accounting for the majority of that figure. Urological cancers affect the male and female urinary tract and the male reproductive organs. Prostate cancer is the most prevalent of these malignancies. A number of common etiologic factors have been strongly characterized as raising the risk of developing urological cancers, including age, chronic inflammation, gender, obesity, tobacco usage and heritable cancer syndromes. The risk of cancer increases greatly in patients over the age of 65. Populations in developed countries are projected to become increasingly aged and show rising obesity incidence, which will drive both cancer prevalence and revenue growth for its treatments. Hormone therapies for prostate cancers and angiogenesis inhibitors for renal cell carcinoma are currently the most commercially successful urological cancer drugs. However, there has been a shift towards the clinical testing of cancer immunotherapies - such as Opdivo, which was recently approved for renal cell carcinoma.
SIZE
RESEARCH
MARKET
DEMAND
BEAM
FORECAST
RESEARCH
AND
SIZE AND
& RESEARCH RESEARCH MARKET
SIZE
RESEARCH
MARKET
DEMAND
FORECAST
RESEARCH
AND
SIZE
No of Pages : 250
AND
& RESEARCH RESEARCH
FORECAST
Report Overview Scope - Global revenues for the urological cancer market are forecast to grow at a Compound Annual Growth Rate (CAGR) of 10.39%, from $17.9 billion in 2015 to $35.9 billion in 2022. Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period? - The urologic oncology pipeline is large and diverse, and contains 817 products. How does the composition of the pipeline compare with that of the existing market? Reasons to buy - Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis - Visualize the composition of the urological cancer market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players - Analyze the urological cancer pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications
SIZE
RESEARCH
MARKET
DEMAND
BEAM
FORECAST
RESEARCH
AND
SIZE AND
& RESEARCH RESEARCH MARKET
SIZE
RESEARCH
MARKET
DEMAND
FORECAST
RESEARCH
AND
SIZE
No of Pages : 250
AND
& RESEARCH RESEARCH
FORECAST
Table of Content 1 Table of Contents 2 Introduction 9 2.1 Disease Cluster Introduction 9 2.2 Symptoms 9 2.3 Etiology and Pathophysiology 10 3 Key Marketed Products 23 3.1 Overview 23 4 Pipeline Landscape Assessment 35 5 Multi-Scenario Market Forecast to 2022 70 5.1 Overall Market Size 70 5.2 Generic Penetration 72 5.3 Revenue Forecast by Molecular Target 75 6 Company Analysis and Positioning 80 6.1 Revenue and Market Share Analysis by Company 81 7 Strategic Consolidations 95 8 Appendix 107 Enquire Here>>> http://www.researchbeam.com/global-urologicalcancer-to-2022-strong-growth-driven-by-rising-prevalence-increaseduptake-of-hormone-therapies-and-approval-of-novel-biologicsmarket/enquire-about-report
Contact
SIZE
RESEARCH
MARKET
DEMAND
BEAM
FORECAST
RESEARCH
AND
SIZE
Visit us at :
AND
& RESEARCH RESEARCH
DEMAND
SIZE
TELEPHONE: +1 (800) 910-6452 E-MAIL: help@researchbeam.com
MARKET
MARKET
FORECAST
RESEARCH
http://www.researchbeam.com/global-urological-cancer-to-2022strong-growth-driven-by-rising-prevalence-increased-uptake-ofhormone-therapies-and-approval-of-novel-biologics-market
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States
RESEARCH
AND
SIZE
No of Pages : 250
AND
& RESEARCH RESEARCH
FORECAST